Literature DB >> 10741795

Quantitative bone scintigraphy. A methodological evaluation in prostate cancer.

A Rydh1, K R Ahlström, A Larsson, L Johansson, J E Damber, R Tomiç, S O Hietala.   

Abstract

PURPOSE: To evaluate a simple method for quantification of focal activity in bone scintigraphy (BS).
MATERIAL AND METHODS: The gamma camera was calibrated using a phantom. Quantitative bone scintigraphy (QBS) was performed on 11 men recently diagnosed with prostate cancer (PCa), for whom routine BS showed involvement of the skeleton. Following endocrine therapy for 4 to 8 months, a second QBS was performed. Changes in QBS values were then compared to changes in serum levels of prostate-specific antigen (PSA).
RESULTS: PSA response indicating regression of PCa was accompanied by a decrease in the QBS value in 8 of the 11 patients. The overall mean error of the QBS values was 15%.
CONCLUSION: QBS according to this method is a relatively simple procedure that might contribute to objective evaluation of therapeutic effects in skeletal metastases, although its validity must be tested in a larger clinical material.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741795     DOI: 10.1080/028418500127345028

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Premature conclusions may harm good ideas.

Authors:  Anton Staudenherz; Helmut Sinzinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

2.  18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin).

Authors:  Gary Cook; Chris Parker; Sue Chua; Bernadette Johnson; Anne-Kirsti Aksnes; Val J Lewington
Journal:  EJNMMI Res       Date:  2011-06-07       Impact factor: 3.138

Review 3.  The development of musculoskeletal radiology for 100 years as presented in the pages of Acta Radiologica.

Authors:  Mats Geijer; Fatih Inci; Nektarios Solidakis; Pawel Szaro; Bariq Al-Amiry
Journal:  Acta Radiol       Date:  2021-10-19       Impact factor: 1.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.